Liu, Drolaiz H. W.
Kim, Young-Woo
Sefcovicova, Nina
Laye, Jon P.
Hewitt, Lindsay C.
Irvine, Andrew F.
Vromen, Vincent
Janssen, Yannick
Davarzani, Naser
Fazzi, Gregorio E.
Jolani, Shahab
Melotte, Veerle http://orcid.org/0000-0002-9459-123X
Magee, Derek R.
Kook, Myeong-Cherl
Kim, Hyunki
Langer, Rupert http://orcid.org/0000-0001-9491-3609
Cheong, Jae-Ho
Grabsch, Heike I. http://orcid.org/0000-0001-9520-6228
Article History
Received: 1 September 2022
Revised: 16 March 2023
Accepted: 23 March 2023
First Online: 7 April 2023
Competing interests
: DRM is director of HeteroGenius Limited. RL received consulting fees from Astellas, Janssen, Roche, MSD not related to the current study. HIG received consulting fees from AstraZeneca and BMS not related to the current study. The remaining authors declare no competing interests.
: The study was conducted in compliance with the Declaration of Helsinki and was approved by the Institutional Review Boards of all participating institutions. The local institutional review boards, which waived the need for patient informed consent for this retrospective study.